These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38563451)
21. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy. Gidal BE; Pitterle ME; Spencer NW; Maly MM J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785 [TBL] [Abstract][Full Text] [Related]
22. Meropenem as an antidote for intentional valproic acid overdose. Thomas C; Priano J; Smith TL Am J Emerg Med; 2020 Mar; 38(3):690.e1-690.e2. PubMed ID: 31980292 [TBL] [Abstract][Full Text] [Related]
23. Drug treatment of epilepsy in elderly people: focus on valproic Acid. Stephen LJ Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314 [TBL] [Abstract][Full Text] [Related]
24. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis. Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113 [TBL] [Abstract][Full Text] [Related]
25. Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy. Chen J; Su Q; Qin J; Zhou Y; Ruan H; Chen Z; Chen Z; Li H; Zhou Y; Zhou S; Wang X; Zhou L; Huang M Drug Metab Pharmacokinet; 2019 Jun; 34(3):165-171. PubMed ID: 30952578 [TBL] [Abstract][Full Text] [Related]
26. Drug interaction between valproic acid and meropenem: a case report. Suntimaleeworakul W; Patharachayakul S; Chusri S J Med Assoc Thai; 2012 Feb; 95(2):293-5. PubMed ID: 22435264 [TBL] [Abstract][Full Text] [Related]
27. [Effect of modal computer-based alerts on the prescription of valproic acid and meropenem]. Vélez-Díaz-Pallarés M; Vicente-Oliveros N; Delgado-Silveira E; Pérez-Menéndez-Conde C; Álvarez-Díaz A; Bermejo-Vicedo T Rev Calid Asist; 2014; 29(1):17-21. PubMed ID: 24120078 [TBL] [Abstract][Full Text] [Related]
28. Meropenem for management of valproic acid overdose: a case report. Muñoz-Pichuante D; Villa-Zapata L; Lolas R Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32609645 [TBL] [Abstract][Full Text] [Related]
29. Seizure worsening caused by decreased serum valproate during meropenem therapy. Santucci M; Parmeggiani A; Riva R J Child Neurol; 2005 May; 20(5):456-7. PubMed ID: 15968935 [TBL] [Abstract][Full Text] [Related]
30. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis. Yoon HY; Ahn MH; Yee J; Lee N; Han JM; Gwak HS Eur J Clin Pharmacol; 2020 Aug; 76(8):1053-1058. PubMed ID: 32385545 [TBL] [Abstract][Full Text] [Related]
31. A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Jannuzzi G; Cian P; Fattore C; Gatti G; Bartoli A; Monaco F; Perucca E Epilepsia; 2000 Feb; 41(2):222-30. PubMed ID: 10691121 [TBL] [Abstract][Full Text] [Related]
32. Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients. Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Tang J; Xiao J; Chen XP Pharmacogenomics; 2016 Jul; 17(11):1219-1225. PubMed ID: 27406852 [TBL] [Abstract][Full Text] [Related]
33. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients]. Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473 [TBL] [Abstract][Full Text] [Related]
34. A rapid and simple HPLC-MS/MS method for the simultaneous quantification of valproic acid and its five metabolites in human plasma and application to study pharmacokinetic interaction in Chinese epilepsy patients. Wen D; Chen Z; Yang C; Liu H; Li H; Chen J; Dai Q; Zhong G; Qin J; Ni G; Huang M; Zhou L; Wang X J Pharm Biomed Anal; 2018 Feb; 149():448-456. PubMed ID: 29169113 [TBL] [Abstract][Full Text] [Related]
35. Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus. Spriet I; Meersseman W; De Troy E; Wilmer A; Casteels M; Willems L Am J Health Syst Pharm; 2007 Jan; 64(1):54-8. PubMed ID: 17189580 [TBL] [Abstract][Full Text] [Related]
36. Unusual drug reaction between valproate sodium and meropenem. Yoon H; Kim DH Int J Clin Pharm; 2013 Jun; 35(3):316-8. PubMed ID: 23483443 [TBL] [Abstract][Full Text] [Related]
37. Panipenem-betamipron and decreases in serum valproic acid concentration. Yamagata T; Momoi MY; Murai K; Ikematsu K; Suwa K; Sakamoto K; Fujimura A Ther Drug Monit; 1998 Aug; 20(4):396-400. PubMed ID: 9712464 [TBL] [Abstract][Full Text] [Related]
38. Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. Nakashima H; Oniki K; Nishimura M; Ogusu N; Shimomasuda M; Ono T; Matsuda K; Yasui-Furukori N; Nakagawa K; Ishitsu T; Saruwatari J PLoS One; 2015; 10(10):e0141266. PubMed ID: 26484865 [TBL] [Abstract][Full Text] [Related]
39. Valproic acid pharmacokinetics in children. II. Discontinuation of concomitant antiepileptic drug therapy. Cloyd JC; Kriel RL; Fischer JH Neurology; 1985 Nov; 35(11):1623-7. PubMed ID: 3932898 [TBL] [Abstract][Full Text] [Related]
40. Clinical significance of CYP2C9-status guided valproic acid therapy in children. Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]